We found GSK2879552 failed to suppress MC38 tumor growth in TCRα KO mice (Fig. 1g, h), suggesting that GSK2879552 acts on LSD1 in T cells to augment the antitumor effect, similar to the impact of T cell-specific LSD1 depletion, in certain tumors. The gene discussed is KDM1A; the disease is neoplasm.